Friday 30 November 2018

AI researchers join forces to develop the 'ImageNet' of generative drug discovery

(InSilico Medicine, Inc.) Insilico Medicine contributes to the new platform MOSES (Molecular Sets), described in the paper titled "Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models".

from EurekAlert! - Social and Behavioral Science https://ift.tt/2PaJ73m

No comments:

Post a Comment